The Bharat Cancer Genome Atlas (BCGA) will be an open-access genomic database to improve understanding of cancer in India, facilitate targeted therapies and personalized treatment, and create effective early detection methods. https://lnkd.in/gfTXMzgc

Engineered “natural killer” cells could help fight cancer!! A new study identifies genetic modifications that make these immune cells, known as CAR-NK cells, more effective at destroying cancer cells. One of the newest weapons that scientists have developed against cancer is a type of engineered immune cell known as CAR-NK (natural killer) cells. Similar to CAR-T cells, these cells can be programmed to attack cancer cells. Link in the first comment! 👇 "Stay ahead of the curve with the latest breakthroughs and insights—subscribe to our newsletter and never miss an update!" #Immunotherapy #CancerResearch #CancerTreatment #CellTherapy #CAR‑NK #NKCells #BiomedicalResearch #Biotech #HealthInnovation #GeneticEngineering #LifeSciences Source: MIT news.

DIAGNOSTICS: Agilus Diagnostics has launched its ground-breaking AgilusEDGE Comprehensive Genomic Profile (CGP) Rapid at its state-of-the-art Reference Laboratory in #Gurugram. More details: https://lnkd.in/gp_YBPe4 #genomics #cancer #lab #tests #cgp #agilusedge #biovoicenews

𝐆𝐞𝐧𝐞𝐭𝐢𝐜𝐬 & 𝐂𝐚𝐧𝐜𝐞𝐫 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 Did you know? Men carrying BRCA1 and BRCA2 mutations face a significantly higher risk of developing aggressive prostate cancer. Experts now recommend that such individuals undergo annual prostate cancer screening, as early detection can dramatically improve outcomes. 👉 𝑮𝒆𝒏𝒆𝒕𝒊𝒄 𝒕𝒆𝒔𝒕𝒊𝒏𝒈 𝒂𝒏𝒅 𝒄𝒐𝒖𝒏𝒔𝒆𝒍𝒊𝒏𝒈 𝒑𝒍𝒂𝒚 𝒂 𝒗𝒊𝒕𝒂𝒍 𝒓𝒐𝒍𝒆 𝒊𝒏 𝒊𝒅𝒆𝒏𝒕𝒊𝒇𝒚𝒊𝒏𝒈 𝒂𝒕-𝒓𝒊𝒔𝒌 𝒊𝒏𝒅𝒊𝒗𝒊𝒅𝒖𝒂𝒍𝒔 𝒂𝒏𝒅 𝒈𝒖𝒊𝒅𝒊𝒏𝒈 𝒑𝒓𝒆𝒗𝒆𝒏𝒕𝒊𝒗𝒆 𝒉𝒆𝒂𝒍𝒕𝒉𝒄𝒂𝒓𝒆 𝒔𝒕𝒓𝒂𝒕𝒆𝒈𝒊𝒆𝒔. 🧬 This is another reminder of how personalized medicine and genomics are transforming cancer prevention and management. 𝐑𝐞𝐚𝐝 𝐌𝐨𝐫𝐞: https://lnkd.in/ge3hPP35 #Genetics #CancerScreening #BRCA #ProstateCancer #GeneticCounseling #PrecisionMedicine

🎙️ In this OncLive On Air episode, Stephen Liu, MD, of Lombardi Comprehensive Cancer Center dives into how early biomarker testing enhances the use of tepotinib for NSCLC with MET exon 14 skipping mutations. 💡 What you’ll hear: The critical timing of testing and genomic profiling How results influence sequencing, combination strategies, and patient selection Real-world challenges and strategies to optimize outcomes 👉 Listen here: https://lnkd.in/eNAKHJmp #NSCLC #METexon14 #PrecisionOncology #Biomarkers #Tepotinib #OncologyPodcast

Editorial: Increasing lung cancer screening rates with digital tools will require integration with broader system supports to reach populations at highest risk and address persistent disparities. https://ja.ma/473R0ms

At the Cancer Genomics Conference in Namibia, our Co-Founder Bren Sambunathan joined the Expert Panel Discussion on “Role of AI Technology in Cancer Screening and Treatment.” He shared insights on how AI can enable earlier detection, precision diagnostics, and more equitable access to care, emphasizing the importance of collaboration between governments, academia, and innovators to scale impact. #CancerGenomics #OncocareAlliance #AIinHealthcare #Africa #Namibia #CancerScreening #CancerTreatment

🧬 Cancer Has Many Layers: Early Detection Should Too 🧬 Dr. Dino Prato of Envita Medical Centers explains how multi-layer genetic testing and advanced biomarker tracking are transforming early cancer detection — revealing hidden risks long before they appear on standard scans. 🎗️ 💡 It’s not just about finding cancer early… it’s about finding it accurately. 🎥 Watch the full podcast now: https://lnkd.in/gy76T2Zk #CancerDetection #EarlyDetection #BreastCancerAwareness #PrecisionMedicine #GeneticTesting #CancerScreening #Oncology #CTCs #CancerResearch #EnvitaDifference #TargetedTherapy #MedicalInnovation #DrPrato #IntegrativeOncology

IWMF continues to power a global research network, supporting 32 academic labs committed to transforming WM from an incurable disease to one that can be fully eradicated. One of our latest grants supports Dr. Constantine Mitsiades at the Dana-Farber Cancer Institute in Boston. Dr. Mitsiades is applying a proven, high-impact strategy to WM: utilizing the Nobel Prize-winning CRISPR gene-editing tool to conduct detailed "gene screens." This methodology allows researchers to efficiently test thousands of cancer cells in parallel, identifying the specific genetic dependencies the cancer relies on to survive. By creating this first-ever blueprint of cancer's control switches, the team is laying the foundation for the next generation of highly targeted therapies. Dr. Mitsiades previously applied this strategy to successfully shape multiple myeloma clinical trials, demonstrating its significant potential for the WM community. This groundbreaking work is made possible by you. Thank you for powering research that transforms hope into reality. https://conta.cc/46ynaGh #CancerResearch #CRISPR #GeneEditing #DanaFarber

🎉Congratulations to Hadi Akbarzadeh Khorshidi & colleagues from our Cancer Health Services Research Group, who have published a new study in Discover Oncology! The paper uses Systems Analysis to investigate the use of Whole Genome Sequencing (WGS) in standard healthcare, providing insights that can be used by policy makers to determine how best to implement WGS in healthcare systems. Whole Genome Sequencing provides crucial information to clinicians that can expand options for #precisionmedicine in cancer care, with the potential to drastically improve patient outcomes. ➡️ Read the study: https://lnkd.in/gX7jvhYB